Quest Diagnostics IncNYSE:DGX
- LAST PRICE137.3350
- TODAY'S CHANGE (%)0.3950 (0.2884%)
- Bid / Lots137.2200/ 1
- Ask / Lots137.3600/ 4
- Open / Previous Close137.2200 / 136.9400
- Day Range
- 52 Week Range
- Volume169,463
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DGX |
|---|---|---|
| 09:32 ET | 5088 | 137.22 |
| 09:41 ET | 152 | 136.95 |
| 09:43 ET | 200 | 137.095 |
| 09:45 ET | 200 | 136.87 |
| 09:50 ET | 100 | 137.09 |
| 09:52 ET | 2167 | 137.36 |
| 09:54 ET | 500 | 137.35 |
| 09:56 ET | 2167 | 137.58 |
| 09:57 ET | 2508 | 137.58 |
| 09:59 ET | 1795 | 137.265 |
| 10:01 ET | 206 | 137.11 |
| 10:06 ET | 115 | 137.245 |
| 10:08 ET | 448 | 137.15 |
| 10:10 ET | 100 | 137.15 |
| 10:12 ET | 100 | 137.165 |
| 10:14 ET | 1492 | 137.43 |
| 10:15 ET | 100 | 137.39 |
| 10:17 ET | 500 | 137.46 |
| 10:19 ET | 100 | 137.365 |
| 10:21 ET | 700 | 136.985 |
| 10:24 ET | 1807 | 136.81 |
| 10:26 ET | 3563 | 136.87 |
| 10:32 ET | 303 | 136.69 |
| 10:33 ET | 1477 | 136.825 |
| 10:39 ET | 1000 | 136.9 |
| 10:42 ET | 700 | 137.05 |
| 10:44 ET | 200 | 136.9297 |
| 10:46 ET | 300 | 137.055 |
| 10:51 ET | 200 | 137.05 |
| 10:53 ET | 300 | 137.115 |
| 10:55 ET | 595 | 137.225 |
| 10:57 ET | 400 | 137.195 |
| 11:00 ET | 100 | 137.125 |
| 11:02 ET | 815 | 137.19 |
| 11:04 ET | 2279 | 137.2 |
| 11:08 ET | 500 | 137.16 |
| 11:09 ET | 1807 | 137.27 |
| 11:13 ET | 725 | 137.3 |
| 11:15 ET | 890 | 137.25 |
| 11:18 ET | 1114 | 137.165 |
| 11:22 ET | 800 | 137.1 |
| 11:24 ET | 100 | 137.175 |
| 11:26 ET | 1190 | 137.28 |
| 11:27 ET | 100 | 137.235 |
| 11:29 ET | 3558 | 137.17 |
| 11:31 ET | 845 | 137.01 |
| 11:33 ET | 1893 | 137.165 |
| 11:36 ET | 100 | 137.28 |
| 11:38 ET | 200 | 137.325 |
| 11:40 ET | 1988 | 137.32 |
| 11:42 ET | 100 | 137.355 |
| 11:44 ET | 537 | 137.256 |
| 11:45 ET | 1219 | 137.4 |
| 11:47 ET | 757 | 137.47 |
| 11:49 ET | 869 | 137.565 |
| 11:51 ET | 2277 | 137.47 |
| 11:54 ET | 207 | 137.375 |
| 11:56 ET | 200 | 137.43 |
| 11:58 ET | 650 | 137.425 |
| 12:00 ET | 1934 | 137.21 |
| 12:02 ET | 165 | 137.28 |
| 12:03 ET | 400 | 137.31 |
| 12:05 ET | 100 | 137.35 |
| 12:07 ET | 1120 | 137.27 |
| 12:12 ET | 1490 | 137.33 |
| 12:14 ET | 600 | 137.21 |
| 12:16 ET | 100 | 137.13 |
| 12:20 ET | 1833 | 137.09 |
| 12:21 ET | 3175 | 137.125 |
| 12:23 ET | 300 | 137.01 |
| 12:25 ET | 100 | 137.01 |
| 12:27 ET | 700 | 136.91 |
| 12:30 ET | 500 | 136.88 |
| 12:32 ET | 8539 | 136.94 |
| 12:34 ET | 1042 | 136.69 |
| 12:36 ET | 716 | 136.56 |
| 12:38 ET | 4651 | 136.55 |
| 12:39 ET | 1691 | 136.67 |
| 12:41 ET | 300 | 136.57 |
| 12:43 ET | 100 | 136.69 |
| 12:45 ET | 1000 | 136.73 |
| 12:50 ET | 300 | 136.53 |
| 12:52 ET | 200 | 136.53 |
| 12:54 ET | 600 | 136.47 |
| 12:56 ET | 900 | 136.425 |
| 12:57 ET | 1100 | 136.45 |
| 12:59 ET | 746 | 136.45 |
| 01:01 ET | 1600 | 136.555 |
| 01:03 ET | 500 | 136.56 |
| 01:08 ET | 100 | 136.575 |
| 01:12 ET | 1049 | 136.67 |
| 01:14 ET | 822 | 136.87 |
| 01:21 ET | 558 | 136.865 |
| 01:26 ET | 500 | 137.22 |
| 01:28 ET | 940 | 137.22 |
| 01:30 ET | 1101 | 137.03 |
| 01:32 ET | 100 | 137.055 |
| 01:33 ET | 100 | 137.03 |
| 01:35 ET | 518 | 137.055 |
| 01:37 ET | 100 | 137.13 |
| 01:42 ET | 100 | 137.09 |
| 01:48 ET | 1003 | 137.27 |
| 01:50 ET | 400 | 137.335 |
| 01:53 ET | 291 | 137.335 |
Today
Yesterday
May 6, 2024
Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements With PathAI, from 2:01PM ET on Monday May 06, 2024 by Dow Jones
2:01PM ET on Monday May 06, 2024 by Dow JonesQuest Diagnostics Names Murali Balakumar Senior Vice President and Chief Information and Digital Officer, from 9:40AM ET on Monday May 06, 2024 by Dow Jones
9:40AM ET on Monday May 06, 2024 by Dow JonesPress Release: Quest Diagnostics Names Murali Balakumar Senior Vice President and Chief Information and Digital Officer, from 9:40AM ET on Monday May 06, 2024 by Dow Jones
9:40AM ET on Monday May 06, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Quest Diagnostics Inc | 15.2B | 18.5x | +7.78% |
Laboratory Corporation of America Holdings | 17.0B | 44.2x | -13.71% |
DaVita Inc | 12.1B | 15.5x | +15.72% |
Healthpeak Properties Inc | 13.5B | 54.3x | -20.31% |
Solventum Corp | 11.3B | 8.5x | --- |
Ventas Inc | 19.1B | -261.4x | --- |
Company Information
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It provides diagnostic information services for infectious diseases, such as tuberculosis (e.g., T.SPOT.TB and Quantiferon offerings) and tick-borne disease (e.g., Accutix offering). Its comprehensive offerings in drug monitoring and toxicology, in neurology diagnostics, in advanced cardiovascular diagnostic information services (e.g. CARDIO IQ and Cleveland HeartLab offerings through its Cardiometabolic Center of Excellence), and in cancer diagnostics. Its Diagnostic Solutions business consists of its risk assessment services and healthcare information technology businesses. Its risk assessment service, ExamOne, is a provider of risk assessment services for the life insurance industry in North America.
Contact Information
- Headquarters
- 500 Plaza DriveSECAUCUS, NJ, United States 07094
- Phone
- 973-520-2700
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board, President, Chief Executive Officer
- James Davis
- Chief Financial Officer, Executive Vice President
- Sam Samad
- Senior Vice President, Chief Information and Digital Officer
- Murali Balakumar
- Senior Vice President, General Counsel
- Michael Prevoznik
- Senior Vice President, Chief Commercial Officer
- Mark Delaney
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $15.2B |
|---|---|
Revenue (TTM) | $9.3B |
Shares Outstanding | 111.1M |
Dividend Yield | 2.18% |
Annual Dividend Rate | 3.0000 USD |
Ex-Dividend Date | 04-05-24 |
Pay Date | 04-22-24 |
Beta | 0.89 |
EPS | $7.43 |
Book Value | $56.82 |
P/E Ratio | 18.5x |
Price/Sales (TTM) | 1.6 |
Price/Cash Flow (TTM) | 11.5x |
Operating Margin | 13.54% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
